Nautilus Biotechnology NAUT Income Statement (2020-2026)

NASDAQ NAUT
$1.12 +0.19 (+20.70%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Nautilus Biotechnology Quarterly Income Statement

Periods 25 quarters
Latest Jun 2026

Nautilus Biotechnology reported revenue of $0.19M and net income of -$14.47M for the quarter ended Jun 2026. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
124.17M84.46M124.46M124.56M124.72M124.87M124.87M124.93M124.94M125.07M125.27M125.41M125.56M126.11M126.15M126.31M126.31M126.47M127.07M127.22M
Revenue & cost
Revenue
0.19M
Gross Profit
0.17M
Operating items
Research & DevelopmentR&D
8.24M9.89M9.66M8.86M9.57M9.59M10.88M11.91M12.00M12.47M12.93M12.44M12.29M12.82M11.54M10.39M9.61M9.57M9.71M9.61M
Selling, General & AdministrativeSG&A
6.32M6.92M6.36M6.62M6.25M6.72M7.18M7.10M7.08M7.54M8.68M8.35M6.81M7.16M7.31M6.70M5.87M5.85M6.42M6.33M
Other Operating ExpensesOther Opex
Operating ExpensesOpex
14.57M16.82M16.02M15.47M15.82M16.30M18.06M19.02M19.07M20.00M21.61M20.79M19.10M19.98M18.84M17.10M15.47M15.42M16.12M15.94M
Operating IncomeOp. Inc
-17.10M-15.76M
EBIT
-17.10M-15.76M
Non-operating items
Non Operating Interest Expenses
0.01M0.00M0.01M0.06M0.02M0.02M0.04M0.02M0.01M0.01M0.01M
Non Operating Investment Income
Interest & Investment IncomeInt & Inv Inc
0.14M0.16M0.26M0.78M1.89M2.89M3.10M3.22M3.20M3.03M2.88M2.80M2.67M2.43M2.23M2.08M1.90M1.65M1.44M1.31M
Other Non Operating IncomeOther Non Op Inc.
-0.07M0.01M-0.13M-0.01M-0.02M-0.01M
Non Operating IncomeNon Op. Inc.
0.06M0.13M0.26M0.78M1.76M2.90M3.10M3.21M3.20M2.98M2.88M2.78M2.65M2.39M2.23M2.06M1.90M1.64M1.43M1.29M
Net income details
EBT
-15.03M-14.46M
Profit After TaxPAT
-14.50M-16.86M-16.13M-14.90M-15.18M-13.38M-14.96M-17.24M-15.88M-16.84M-19.22M-18.01M-16.45M-17.59M-16.61M-15.03M-13.57M-13.78M-15.03M-14.47M
Income from Continuing OperationsIncome (Continuing)
-15.03M-14.46M
Consolidated Net IncomeConsol Net Inc.
-15.03M-14.46M
Income towards Parent CompanyParent Net Inc
-15.03M-14.46M
Net Income towards Common StockholdersNet Income
-15.03M-14.46M
Additional items
EPS (Basic)
-0.12-0.11
EPS (Diluted)
-0.12-0.11
Shares Outstanding
124.11M84.46M124.42M124.49M124.65M124.59M124.59M124.60M124.93M124.92M125.14M125.32M125.45M125.43M126.14M126.20M126.31M126.26M126.63M127.14M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
124.11M84.46M124.42M124.49M124.65M124.59M124.59M124.60M124.93M124.92M125.14M125.32M125.45M125.43M126.14M126.20M126.31M126.26M126.63M127.14M
EBITDA
-17.10M-15.76M
Interest ExpensesInt Expense
0.01M0.00M0.01M0.06M0.02M0.02M0.04M0.02M0.01M0.01M0.01M